Catecholaminergic polymorphic ventricular tachycardia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 8: | Line 8: | ||
Catecholaminergic polymorphic ventricular tachycardia must be differentiated from [[Arrhythmogenic right ventricular dysplasia]], Short-coupled [[ventricular tachycardia]] (SC-[[torsade de pointes]] [TdP]), [[Long QT syndrome]] and [[Andersen-Tawil syndrome]]. | Catecholaminergic polymorphic ventricular tachycardia must be differentiated from [[Arrhythmogenic right ventricular dysplasia]], Short-coupled [[ventricular tachycardia]] (SC-[[torsade de pointes]] [TdP]), [[Long QT syndrome]] and [[Andersen-Tawil syndrome]]. | ||
==Differentiating | ==Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases== | ||
Catecholaminergic polymorphic ventricular tachycardia must be differentiated from other diseases that cause [[syncope]], [[ventricular tachycardia]], and [[sudden cardiac death]], such as: | Catecholaminergic polymorphic ventricular tachycardia must be differentiated from other diseases that cause [[syncope]], [[ventricular tachycardia]], and [[sudden cardiac death]], such as: | ||
*[[Arrhythmogenic right ventricular dysplasia]] | *[[Arrhythmogenic right ventricular dysplasia]] | ||
Line 15: | Line 15: | ||
*[[Andersen-Tawil syndrome]] | *[[Andersen-Tawil syndrome]] | ||
===Differentiating | ===Differentiating Catecholaminergic polymorphic ventricular tachycardia from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]=== | ||
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6]. | On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6]. |
Revision as of 06:18, 24 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Catecholaminergic polymorphic ventricular tachycardia must be differentiated from Arrhythmogenic right ventricular dysplasia, Short-coupled ventricular tachycardia (SC-torsade de pointes [TdP]), Long QT syndrome and Andersen-Tawil syndrome.
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases
Catecholaminergic polymorphic ventricular tachycardia must be differentiated from other diseases that cause syncope, ventricular tachycardia, and sudden cardiac death, such as:
- Arrhythmogenic right ventricular dysplasia
- Short-coupled ventricular tachycardia (SC-torsade de pointes [TdP])
- Long QT syndrome
- Andersen-Tawil syndrome
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]
On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
Differential Diagnosis 1 | |||||||||||||||
Differential Diagnosis 2 | |||||||||||||||
Differential Diagnosis 3 | |||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Differential Diagnosis 4 | |||||||||||||||
Differential Diagnosis 5 | |||||||||||||||
Differential Diagnosis 6 |